Advisor Group Holdings, Inc. Arcturus Therapeutics Holdings Inc. Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,163 shares of ARCT stock, worth $47,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,163

Previous 1,370 57.88%

Holding current value

$47,326

Previous $17,000 64.71%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	BUY	$8.91 - $14.41 $7,065 - $11,427	793 Added 57.88%	2,163 $28,000
Q2 2025 Aug 13, 2025	SELL	$8.91 - $14.41 $490 - $792	-55 Reduced 3.86%	1,370 $17,000
Q1 2025 May 12, 2025	BUY	$10.59 - $20.83 $3,854 - $7,582	364 Added 34.31%	1,425 $15,000
Q4 2024 Jun 06, 2025	SELL	$14.82 - $25.48 $5,394 - $9,274	-364 Reduced 25.54%	1,061 $18,000
Q4 2024 Feb 07, 2025	BUY	$14.82 - $25.48 $5,809 - $9,988	392 Added 58.59%	1,061 $18,000
Q3 2024 Nov 13, 2024	SELL	$18.08 - $25.38 $18 - $25	-1 Reduced 0.15%	669 $15,000
Q2 2024 Aug 13, 2024	SELL	$24.35 - $44.39 $5,064 - $9,233	-208 Reduced 23.69%	670 $16,000
Q1 2024 May 10, 2024	SELL	$31.23 - $42.99 $2,935 - $4,041	-94 Reduced 9.67%	878 $29,000
Q4 2023 Feb 12, 2024	SELL	$17.71 - $32.97 $13,087 - $24,364	-739 Reduced 43.19%	972 $30,000
Q3 2023 Nov 13, 2023	BUY	$25.44 - $37.35 $1,043 - $1,531	41 Added 2.46%	1,711 $43,000
Q2 2023 Aug 10, 2023	SELL	$23.94 - $32.36 $3,255 - $4,400	-136 Reduced 7.53%	1,670 $47,000
Q1 2023 May 12, 2023	SELL	$14.72 - $23.97 $2,576 - $4,194	-175 Reduced 8.83%	1,806 $43,000
Q4 2022 Feb 10, 2023	SELL	$14.14 - $23.06 $4,694 - $7,655	-332 Reduced 14.35%	1,981 $33,000
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $1,800 - $3,053	-138 Reduced 5.63%	2,313 $33,000
Q2 2022 Aug 10, 2022	SELL	$12.26 - $31.17 $858 - $2,181	-70 Reduced 2.78%	2,451 $37,000
Q1 2022 May 04, 2022	SELL	$17.64 - $39.57 $26,054 - $58,444	-1,477 Reduced 36.94%	2,521 $68,000
Q3 2021 Nov 05, 2021	SELL	$27.88 - $58.25 $13,577 - $28,367	-487 Reduced 10.86%	3,998 $191,000
Q2 2021 Aug 02, 2021	SELL	$25.79 - $42.11 $537,618 - $877,825	-20,846 Reduced 82.29%	4,485 $151,000
Q1 2021 May 13, 2021	BUY	$38.75 - $86.92 $794,685 - $1.78 Million	20,508 Added 425.21%	25,331 $1.05 Million
Q4 2020 Feb 10, 2021	BUY	$34.61 - $123.66 $62,747 - $224,195	1,813 Added 60.23%	4,823 $209,000
Q3 2020 Nov 12, 2020	BUY	$37.49 - $63.19 $47,349 - $79,808	1,263 Added 72.3%	3,010 $129,000
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $14,521 - $66,835	1,147 Added 191.17%	1,747 $82,000
Q1 2020 May 18, 2020	BUY	$9.31 - $18.26 $5,586 - $10,956	600 New	600 $8,000

Others Institutions Holding ARCT

# of Institutions

171

Shares Held

25.9M

Call Options Held

321K

Put Options Held

136K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $581M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Arcturus Therapeutics Holdings Inc. Transaction History